Cleared Traditional

K052642 - SUTURING WASHER

K052642 is an FDA 510(k) clearance for SUTURING WASHER, manufactured by First Call, Inc.. The device is a Class 2 Cardiovascular device with product code MAB cleared through the Traditional 510(k) pathway after a 113-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2006
Decision
113d
Days
Class 2
Risk

K052642 is an FDA 510(k) clearance for the SUTURING WASHER. Classified as Marker, Cardiopulmonary Bypass (vein Marker) (product code MAB), Class II - Special Controls.

Submitted by First Call, Inc. (Derby, US). The FDA issued a Cleared decision on January 17, 2006 after a review of 113 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all First Call, Inc. devices

FDA 510(k) Submission Details - K052642

510(k) Number K052642 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2005
Decision Date January 17, 2006
Days to Decision 113 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 125d · This submission: 113d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MAB Device Classification - Class 2, Special Controls

Product Code MAB Marker, Cardiopulmonary Bypass (vein Marker)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.